Affiliate disclosure
We earn a commission if you sign up with yourEra through the links on this page. It did not buy a favourable review. The central caveat below — that we could not find enough independent customer evidence to judge this service properly — is stated plainly because it is the most important thing we found.
yourEra is a US telehealth platform focused exclusively on GLP-1 weight loss — no hair loss, no testosterone, no longevity add-ons. It offers compounded medication from $99 a month on a six-month plan, or $149 for a first month then $179 thereafter if you go month-to-month, across a 50-state licensed physician network. What makes it structurally interesting is that it owns the pharmacy that compounds your medication, which almost nobody in this market does. What makes it hard to recommend confidently is that we could find virtually no independent record of what customers actually experience.
Overview
yourEra describes itself as physician-led and vertically integrated. Each patient starts with a clinical assessment, is matched to a physician from its 50-state network, and receives a protocol that is adjusted over time — medication, dosing and combinations — with biometric tracking and at-home diagnostic panels feeding into the picture. The company explicitly positions itself against what it calls a "prescription mill" model.
That is marketing language, and we should treat it as such. But the underlying structure it describes — ongoing dose adjustment against tracked data, rather than a fixed monthly shipment — is the right shape for GLP-1 care, and it is more than most cheap providers attempt. Whether it is delivered as described is precisely what the missing review record leaves unanswered.
yourEra at a Glance
| Medications offered | Compounded GLP-1 medication; the platform focuses exclusively on weight loss |
|---|---|
| Brand-name or compounded | Compounded — not FDA-approved |
| Consultation process | Comprehensive online clinical assessment matched to a physician; no separate consultation fee published |
| Eligibility | Determined at the clinical assessment; specific criteria not published |
| Provider involvement | 50-state licensed physician network with ongoing protocol adjustment, biometric tracking and at-home diagnostic panels |
| Lab requirements | At-home diagnostic panels form part of the programme |
| Pharmacy fulfillment | Named — Galleria Medical Pharmacy, owned by yourEra, plus selected third-party partner pharmacies |
| Shipping frequency | Direct to the patient; no separate shipping charge published |
| Support services | Ongoing clinical relationship described; support responsiveness untested in public reviews |
| Membership fees | None published separately — the plan price is the charge |
| Medication fees | From $99/month on a six-month plan; month-to-month is $149 for the first month then $179 |
| Cancellation policy | Not published |
| Refund policy | Not published |
| Insurance | Not required or accepted — cash pay |
| HSA/FSA | Not stated on the site |
| Availability | All 50 states, via its licensed physician network |
Pricing and the Six-Month Catch
| Plan | Price | Commitment |
|---|---|---|
| Six-month plan | $99/month | 6 months |
| Month-to-month, first month | $149 | None |
| Month-to-month, thereafter | $179/month | None |
At $99, yourEra matches Cora Health and Trimi Health for the cheapest compounded semaglutide we track from a provider that names its pharmacy. That is a strong position.
The structure is unusually honest about the trade-off. Rather than hiding a commitment behind an asterisk, yourEra publishes both routes: $99 if you commit for six months, $179 if you do not. The gap is $80 a month, which is a fair, legible price for flexibility.
What is not published is what happens if you take the six-month plan and stop early. No cancellation or refund terms appear on the pages we reviewed, and that is the gap to close before paying. Given the FDA's pending decision on compounded GLP-1 supply, a six-month commitment with unpublished exit terms is more risk than the $80 saving justifies for most people — start month-to-month.
Owning the Pharmacy: Why It Matters, and Its Limits
yourEra states that prescriptions are compounded through its own pharmacy, Galleria Medical Pharmacy, alongside a network of selected third-party partners for supply redundancy. In a market where the standard answer to "who makes my medication?" is silence, this is a meaningful difference.
It matters for accountability. When MEDVi received an FDA warning letter in February 2026, the specific finding was that its labelling implied it was the compounder when it was not — the agency's objection was to a telehealth brand obscuring who actually made the drug. A company that owns the pharmacy cannot make that mistake, and cannot deflect a quality problem onto an unnamed third party.
Two limits are worth stating. Owning a pharmacy does not make compounded medication FDA-approved — it is not, and yourEra's products have not been evaluated by the FDA for safety, efficacy or quality. And vertical integration cuts both ways: the entity assessing whether your treatment is working also profits from dispensing it, the same conflict we flagged with Male Excel and its in-house lab. Transparency about the arrangement is the mitigation, and yourEra does disclose it.
Eligibility, Contraindications, and Side Effects
yourEra operates in all 50 states and determines eligibility at the clinical assessment; published criteria are not available. See our eligibility guide for what a thorough screen should cover.
Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, warrants specific discussion first.
Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal pain — worst after a dose increase. Serious but less common risks include pancreatitis, gallbladder disease and acute kidney injury caused by dehydration. yourEra's emphasis on ongoing dose adjustment is the right response to this if it works in practice. Our side effects guide covers management.
We are not quoting weight-loss figures for yourEra. It publishes no outcome data for its own patients, and brand-name trial results do not transfer to compounded preparations.
The Missing Track Record
We could not locate a meaningful independent review record for yourEra. No substantive Trustpilot profile, no BBB rating or complaint history, and no significant body of third-party coverage beyond promotional listings.
That is not evidence of a problem. It is the absence of evidence either way, and for a service you would be trusting to compound and ship an injectable prescription medicine, that absence is itself something to weigh.
Everything positive in this review — the owned pharmacy, the 50-state network, the ongoing protocol adjustment, the honest two-tier pricing — comes from what yourEra says about itself. All of it is checkable in principle and none of it is checked here. Compare that with Shed, where a BBB pattern-of-complaints warning revealed problems the marketing did not mention, or Sprout Health, whose structure reads well and whose customers rate it 2.2. Marketing copy and delivered service are different things, and only the review record distinguishes them.
Our rating reflects that uncertainty rather than any specific fault: a promising structure, held below the providers with proven records until there is something to prove it against.
Where Compounded GLP-1s Stand Right Now
yourEra sells compounded medication. Compounded semaglutide and tirzepatide are not FDA-approved, are not generics, and brand-name approval does not extend to them.
The shortages that created this market have ended — tirzepatide in October 2024, semaglutide on 21 February 2025. On 30 April 2026 the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, with the comment period closing on 30 July 2026. Patient-specific 503A compounding remains lawful within narrow limits. yourEra's stated supply redundancy across its own and partner pharmacies is a sensible hedge against that, but it does not remove the risk — which is the strongest argument for taking the month-to-month plan rather than committing six months ahead. Our compounded vs brand-name guide covers the trade-off.
How yourEra Compares
| Provider | Cheapest | Commitment | Pharmacy | Independent record | Our rating |
|---|---|---|---|---|---|
| yourEra | $99 | 6 months | Owns Galleria Medical Pharmacy | Essentially none found | 3.2 / 5 |
| Trimi Health | $99 | 12 months | Two named 503A partners | Tens of reviews | 3.6 / 5 |
| Cora Health | $99 | None | Named, PCAB-accredited | Established | 4.5 / 5 |
All three reach $99. Cora Health gets there with no commitment at all and a PCAB-accredited named pharmacy behind it, which is why it rates highest. yourEra's owned pharmacy is arguably a stronger accountability structure than a named partner — but Cora has demonstrated it works and yourEra has not yet.
Pros and Cons
Pros
- $99/month matches the cheapest compounded GLP-1 pricing we track
- Owns the compounding pharmacy — rare, and strong for accountability
- Names it: Galleria Medical Pharmacy, plus partner redundancy
- Operates in all 50 states with a licensed physician network
- Focused exclusively on weight loss — no low-evidence add-ons
- Both commitment and no-commitment prices published side by side
- Ongoing protocol adjustment with biometric tracking and at-home panels
- No separate membership or consultation fee published
Cons
- Essentially no independent review record — nothing is externally verified
- No BBB rating or complaint history located
- Cancellation and refund terms not published
- The $99 rate requires a six-month commitment with unpublished exit terms
- Compounded only, with no brand-name fallback if supply tightens
- Eligibility criteria not published
- Vertical integration means the prescriber and dispenser share an owner
- Insurance not accepted; HSA/FSA not addressed
- Claims about ongoing optimisation are untested by any public feedback
Who Should Pick It, and Who Should Look Elsewhere
yourEra suits you if the identity and accountability of the compounding pharmacy is your main concern and you are comfortable being an early customer. Owning the pharmacy is a better answer to that question than naming a partner, and $99 is as cheap as this market gets. Take the month-to-month plan at $179 for the first couple of months, satisfy yourself the service works, then move to the six-month rate.
Look elsewhere if you want evidence rather than architecture. Cora Health offers the same $99 with no commitment, a PCAB-accredited named pharmacy and a real track record. Precision Telemed at $139.99 flat is similarly well established. And if you want an FDA-approved product rather than a compounded one, NovoCare Pharmacy sells brand-name semaglutide at $149.
Limitations of This Review
This review is based on yourEra's own site and its affiliate programme materials, checked on 7 August 2026, and it is a thinner evidentiary base than we would like. We could not find a substantive Trustpilot profile, BBB record or independent editorial coverage, so nothing the company says about itself has been corroborated. Cancellation, refund and eligibility terms are not published. We could not independently verify the ownership of Galleria Medical Pharmacy, its licensure, or the 50-state physician network. We have not signed up, been prescribed, or received medication. This rating should be revisited once a review record exists.
Frequently Asked Questions
How much does yourEra cost?
Compounded GLP-1 from $99/month on a six-month plan. Month-to-month is $149 for the first month and $179 thereafter. No separate membership or consultation fee is published.
Which pharmacy does yourEra use?
Its own — Galleria Medical Pharmacy — alongside selected third-party partner pharmacies for supply redundancy. Owning the dispensing pharmacy is unusual in this market and is the strongest structural point in its favour.
Is yourEra legit?
We found nothing suggesting otherwise, but we also found almost no independent evidence either way — no meaningful Trustpilot profile and no BBB record. Treat it as unproven rather than as either verified or suspect, and start on the shortest plan.
Is the medication FDA-approved?
No. yourEra dispenses compounded GLP-1 medication, which is not FDA-approved and has not been evaluated for safety, efficacy or quality. Owning the pharmacy does not change that.
Should I take the six-month plan?
Not initially. It saves $80 a month, but cancellation and refund terms are not published and the company has no track record. Start month-to-month, confirm the service works, and switch once you know.
Verdict
3.2 / 5
The best structural answer to "who compounds my medication?" that we have seen — the provider owns the pharmacy — at the cheapest price in the market, rated down purely because there is almost no independent evidence that any of it works as described.
On paper yourEra is one of the more thoughtfully constructed services we have reviewed: exclusive focus on weight loss rather than a menu of low-evidence add-ons, an owned and named dispensing pharmacy, nationwide physician coverage, ongoing dose adjustment, and honest side-by-side pricing for committing versus not. If it delivers what it describes, it would rate well above this. The rating is 3.2 because "if it delivers" is doing all the work — no Trustpilot record, no BBB file, no published cancellation terms. Try it month-to-month, not six months up front, and let the evidence catch up with the architecture.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from yourEra's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: August 7, 2026
Start Month-to-Month
The $99 rate needs six months and the exit terms are not published. Pay $179 for a month or two first and find out how the service actually performs.